Drug administration safety label

- PharMEDium Services, LLC
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top plan view of a drug administrative safety label of our new design,

FIG. 2 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 3 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 4 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 5 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 6 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 7 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 8 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 9 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design; and,

FIG. 10 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design.

In the drawings, the broken lines represent environmental structure forming no part of the claimed design.

Claims

The ornamental design for drug administration safety label, as shown and described.

Referenced Cited
U.S. Patent Documents
4065343 December 27, 1977 Stumpe
D311423 October 16, 1990 DeSantis
D386212 November 11, 1997 Lambert
5924561 July 20, 1999 Baumgartner et al.
D432176 October 17, 2000 Stevens et al.
6568530 May 27, 2003 Takahashi et al.
D522065 May 30, 2006 Greenstein
D550287 September 4, 2007 Smart et al.
7311205 December 25, 2007 Adler et al.
20070029788 February 8, 2007 Adler
20070252378 November 1, 2007 Chambers
Other references
  • Syringe label for Atropine sulfate, known prior to Dec. 3, 2007, 1 page.
  • Label for alcohol preps, known prior to Dec. 3, 2007, 1 page.
  • IV bag label for 0.9% Sodium Chloride, known prior to Dec. 3, 2007, 1 page.
  • Syringe label for Labetalol Hydrochloride, known prior to Dec. 3, 2007, 1 page.
  • Label for drug vial for 0.9% Sodium Chloride, known prior to Dec. 3, 2007, 1 page.
  • Syringe label for Calcium Chloride, known prior to Dec. 3, 2007, 1 page.
  • Drug delivery device label for Phenylephrine, known prior to Dec. 3, 2007, 1 page.
  • Label for drug vial for Phenylephrine, known prior to Dec. 3, 2007, 1 page.
  • IV bag label for Fentanyl and Ropivacaine, known prior to Dec. 3, 2007, 1 page.
  • Label for drug vial for Vecuronium Bromide, known prior to Dec. 3, 2007, 1 page.
Patent History
Patent number: D588200
Type: Grant
Filed: Dec 3, 2007
Date of Patent: Mar 10, 2009
Assignee: PharMEDium Services, LLC (Lake Forest, IL)
Inventors: Amy E. Langan (Glenview, IL), Richard J. Kruzynski (Long Grove, IL), John A. Kollar (Northbrook, IL), Patricia L. Miyake (Mundelein, IL), Monique L. Kruk (Burlington, WI), Mark F. Wagner (Gurnee, IL)
Primary Examiner: Caron Veynar
Assistant Examiner: Mary Ann Calabrese
Attorney: Bell, Boyd & Lloyd LLP
Application Number: 29/298,328
Classifications
Current U.S. Class: Substantially Rectangular Or Square (D20/27)